1 Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263;
2 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115; Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, MA 02115; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, MA 02115; Division of Cancer Studies, King's College London, London SE1 9RT, United Kingdom massimo_loda@dfci.harvard.edu.